Two Sigma Advisers
TMDX icon

Two Sigma Advisers’s Transmedics TMDX Stock Holding History

Two Sigma Advisers’s Portfolio TMDX Stock Details TMDX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		– Sell
-362,300
Closed -$44.1M – 1954
2025
Q4 		$44.1M Sell
362,300
-61,000
-14% -$7.65M 0.09% 205
2025
Q3 		$47.5M Buy
423,300
+147,900
+54% +$17.3M 0.1% 179
2025
Q2 		$36.9M Buy
+275,400
New +$30.2M 0.08% 230
2023
Q2 		– Sell
-58,400
Closed -$4.42M – 2658
2023
Q1 		$4.42M Buy
58,400
+2,100
+4% +$145K 0.01% 860
2022
Q4 		$3.47M Buy
56,300
+45,300
+412% +$2.41M 0.01% 938
2022
Q3 		$459K Buy
+11,000
New +$478K ﹤0.01% 1880

Other funds holding TMDX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
UBS AM
UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return
NAMI
Nomura Asset Management International Philadelphia, Pennsylvania $66.6B AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Two Sigma Advisers's TMDX Position: Q1 2026 in Review

Two Sigma Advisers sold out of Transmedics (TMDX) in Q1 2026, closing a stake of 362,300 shares — an estimated $44.1M sold.

Two Sigma Advisers first reported a position in TMDX in Q3 2022 and held it in 6 quarters. The position peaked at $47.5M in Q3 2025. 416 funds tracked by Wall St. Rank hold TMDX as of Q1 2026.

  • Two Sigma Advisers reported no remaining Transmedics position as of Q1 2026 after selling out during the quarter.
  • Two Sigma Advisers sold 362,300 Transmedics shares in Q1 2026, an estimated $44.1M.
  • Two Sigma Advisers first reported a position in Transmedics in Q3 2022 and held it in 6 quarters.
  • Two Sigma Advisers's Transmedics position peaked at $47.5M in Q3 2025.
  • 416 funds tracked by Wall St. Rank held Transmedics as of Q1 2026.

Based on Two Sigma Advisers's 13F filing for Q1 2026.